Eucrates Biomedical Acquisition OverviewEucrates Biomedical Acquisition Operating Income
Operating Income for EUCR.
Quarterly Operating Income
$-263192.00
↓ 46.65% YoY
As of Dec 31, 2022
Annual Operating Income (TTM)
$-698578.00
↓ 30.35% YoY
Trailing 12 months ending Dec 31, 2022